Literature DB >> 25267044

Research into practice: management of atrial fibrillation in general practice.

David A Fitzmaurice1, F D Richard Hobbs2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25267044      PMCID: PMC4173721          DOI: 10.3399/bjgp14X682057

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  16 in total

1.  A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.

Authors:  F D R Hobbs; D A Fitzmaurice; J Mant; E Murray; S Jowett; S Bryan; J Raftery; M Davies; G Lip
Journal:  Health Technol Assess       Date:  2005-10       Impact factor: 4.014

2.  Oral anticoagulation management in primary care with the use of computerized decision support and near-patient testing: a randomized, controlled trial.

Authors:  D A Fitzmaurice; F D Hobbs; E T Murray; R L Holder; T F Allan; P E Rose
Journal:  Arch Intern Med       Date:  2000 Aug 14-28

3.  A primary care evaluation of three near patient coagulometers.

Authors:  E T Murray; D A Fitzmaurice; T F Allan; F D Hobbs
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

4.  Evaluation of computerized decision support for oral anticoagulation management based in primary care.

Authors:  D A Fitzmaurice; F D Hobbs; E T Murray; C P Bradley; R Holder
Journal:  Br J Gen Pract       Date:  1996-09       Impact factor: 5.386

5.  Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators.

Authors:  Carl van Walraven; Robert G Hart; Stuart Connolly; Peter C Austin; Jonathan Mant; F D Richard Hobbs; Peter J Koudstaal; Palle Petersen; Francisco Perez-Gomez; J Andre Knottnerus; Beppie Boode; Michael D Ezekowitz; Daniel E Singer
Journal:  Stroke       Date:  2009-01-29       Impact factor: 7.914

6.  External quality assessment for warfarin dosing using computerised decision support software.

Authors:  T P Oppenkowski; E T Murray; H Sandhar; D A Fitzmaurice
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

7.  Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.

Authors:  F D R Hobbs; A K Roalfe; G Y H Lip; K Fletcher; D A Fitzmaurice; J Mant
Journal:  BMJ       Date:  2011-06-23

8.  Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.

Authors:  Jonathan Mant; F D Richard Hobbs; Kate Fletcher; Andrea Roalfe; David Fitzmaurice; Gregory Y H Lip; Ellen Murray
Journal:  Lancet       Date:  2007-08-11       Impact factor: 79.321

9.  Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study.

Authors:  D A Fitzmaurice; D McCahon; J Baker; E T Murray; S Jowett; H Sandhar; R L Holder; F D R Hobbs
Journal:  Fam Pract       Date:  2014-04-12       Impact factor: 2.267

10.  Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.

Authors:  Ajay K Kakkar; Iris Mueller; Jean-Pierre Bassand; David A Fitzmaurice; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Werner Hacke; Gregory Y H Lip; Lorenzo G Mantovani; Alexander G G Turpie; Martin van Eickels; Frank Misselwitz; Sophie Rushton-Smith; Gloria Kayani; Peter Wilkinson; Freek W A Verheugt
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more
  2 in total

1.  Stroke prevention in atrial fibrillation: we can do better.

Authors:  Matt Kearney; Matthew Fay; David A Fitzmaurice
Journal:  Br J Gen Pract       Date:  2016-02       Impact factor: 5.386

2.  Research into practice: management of atrial fibrillation in general practice.

Authors:  Andrew Potter
Journal:  Br J Gen Pract       Date:  2014-12       Impact factor: 5.386

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.